Form D · Biotechnology
Global BioDiagnostics Corp.
Temple, TX · CIK 0001631270
Offering snapshot reported Feb 3, 2015 · SEC filing
- Reported sold
- $1.97M Offering amount: $1.97M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Jan 26, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2015 | Initial | $1,969,352 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-233335
Source: Form D, filed Feb 3, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Saurabh Biswas | Director |
| Roger Kearns | Director |
| John D Manwell | Executive |
| Michael T Norman | Director, Executive |
| Luke Roush | Director |
| Chris N Thornton | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3000 S. 31 St St. Suite 408
Temple, TX, 76502
Temple, TX, 76502